Welia Health Connections
welia health logo
320.679.1212

COVID-19: Medication therapies

January 24, 2022  /   Coronavirus, Press Releases  /   16-minute read

Medication therapies

Welia Health offers several medication therapies for individuals who have tested positive for COVID-19. The use of these medications is prioritized based on those who are most at risk of severe COVID-19 complications. A scoring system, called M-MASS scoring, is used to evaluate those most at risk.

At this time, when demand for COVID-19 medications is high and supply is limited, the Minnesota Department of Health follows an ethical framework for equitable distribution of these medications to patients throughout Minnesota.

Please note the following:

  • You, or your insurance company, will be billed for a visit if you choose to receive any of the available COVID-19 medications.
  • If you are pregnant and test positive for COVID-19, you should see your provider right away.

If you test positive for COVID-19, have calculated your M-MASS** score, and are eligible and interested in receiving COVID-19 medications, please call 320.679.1313 to speak to a Welia Health nurse.

You may also apply for monoclonal antibodies by using the MNRAP (Minnesota Resource Allocation Platform For COVID-19 Treatment) screening process.

COVID-19 vaccines
Medications to treat COVID-19 should not be used in place of vaccination. Welia Health strongly recommends you get vaccinated and boosted to help manage and limit the spread of COVID-19.

 M-MASS eligibility

Calculate your M-MASS score using the following scale. 

Are you:

  • 65 years or older (2 points)
  • Immunocompromised (4 points)
  • 12 years or older and pregnant (4 points)

Do you have:

  • BMI of 35-kg/m2 (2 points)
  • Diabetes (2 points)
  • Chronic kidney disease (3 points)
  • Cardiovascular disease and are 55 years or older (2 points)
  • Chronic respiratory disease and are 55 years or older (2 points)
  • Hypertension (high blood pressure) and are 55 years or older (1 points)

Add your total points and refer to the chart below for eligibility for each medication therapy.

Medication therapies for COVID-19

Paxlovid

Type of medication

Antiviral

Authorized use(s)

Treatment of mild to moderate symptoms in high-risk patients with COVID-19 symptoms.

Age eligibility

Ages 12 years and older

Weight eligibility

88 pounds or more

Other criteria for treatment

  • Test positive for SARS-CoV-2
  • Be within 5 days of the start of symptoms
  • Not pregnant or breastfeeding*
  • Patient must not be hospitalized

Emergency Use Authorization (EUA)

The Food and Drug Administration has issued Emergency Use Authorizations for this medication. It may not be appropriate for all individuals. Learn more by downloading and reviewing fact sheets using the links provided.

M-MASS score

2 or greater

Molnupiravir

Type of medication

Antiviral

Authorized use(s)

Treatment of mild to moderate symptoms in high-risk patients with COVID-19 symptoms.

Age eligibility

Ages 18 years and older

Weight eligibility

88 pounds or more

Other criteria for treatment

  • Test positive for SARS-CoV-2
  • Be within 5 days of the start of symptoms
  • Not pregnant or breastfeeding
  • Patient must not be hospitalized

Emergency Use Authorization (EUA)

The Food and Drug Administration has issued Emergency Use Authorizations for this medication. It may not be appropriate for all individuals. Learn more by downloading and reviewing fact sheets using the links provided.

M-MASS score

Range between 1-3

Sotrovimab

Type of medication

Monoclonal antibody

Authorized use(s)

Treatment of mild to moderate symptoms in high-risk patients with COVID-19 symptoms.

Age eligibility

Ages 12 years and older

Weight eligibility

88 pounds or more

Other criteria for treatment

  • Test positive for SARS-CoV-2
  • Be within 7 days of the start of symptoms
  • Patient must not be hospitalized

Emergency Use Authorization (EUA)

The Food and Drug Administration has issued Emergency Use Authorizations for this medication. It may not be appropriate for all individuals. Learn more by downloading and reviewing fact sheets using the links provided.

M-MASS score

0

MNRAP Screening


*Pregnant women will require an informed consent visit with a physician or advanced practice provider.

Resources for additional information

To view or download a PDF of this information, click the link or button below.

Sources:
Adapted with information from the Minnesota Department of Health:

Scroll to Top
Scroll to Top